Biometrics

Vapor Corp. Unveils E-Cigarette Industry's First Biometric Technology

LAS VEGAS, Jan. 7, 2014 /PRNewswire/ -- from ShowStoppers @ CES 2014 – Vapor Corp. (OTCQB: VPCOD) today announced its Vapor X personalized, rechargeable vaporizer unit will become available to consumers with patent pending fingerprint lock technology in time for the 2014 holiday retail season. There will be a working prototype and early iteration of the product to try today during ShowStoppers at CES 2014, Booth # A5.

In 2013 every corner of the country weighed in on the newest options in alternative smoking devices, making it clear that traditional smoking is on its way to being replaced by "vaping." Now Vapor Corp., a leading publically traded "pure-play" company in the electronic cigarette market, is answering the question on everyone's mind: what comes next?

"The next trend in alternative smoking devices is the personalized vaporizer that incorporates the technology that we expect from our high-end tech devices. Today we are debuting the newest technology in this space," says Kevin Frija, CEO of Vapor Corp. "By incorporating this biometric user identity technology into the Vapor X personal vaporizer, the door is opened to many customizable features. The fingerprint lock security allows customers to protect their device from use by another individual and this same technology will lead to the development of additional features and controls," continues Frija. "Much like the fitness mobile app technology we have seen gain recent popularity, vaporizer users will soon be able to download their 'vaping' statistics through a corresponding mobile application in order to track exactly how often they use the device."

Vaporizers are the rechargeable, customizable, high-end cousin of the disposable electronic cigarette. The Vapor X with patent pending fingerprint lock technology will incorporate biometric technologies in order to keep the device locked and turned off unless the authorized user is present. When first purchased, the device will require an authorized user to be assigned through a fingerprint scan. Once this user is assigned, he or she is the only person who can activate the device. This will not only protect against minors being able to turn on the device, but it will deem the device useless in the case of theft.

Vapor Corp.'s Vapor X personalized, rechargeable vaporizer unit will become available with patent pending fingerprint lock technology in the second half of 2014 to consumers via online and through authorized dealers nationwide. The device will retail for between $199 and $299.

About Vapor Corp.:
Vapor Corp. (OTCQB: VPCO) a publicly traded company, is a leading U.S. based electronic cigarette company, whose brands include Fifty-One®, Krave®, VaporX®, EZ Smoker®, Alternacig®, Green Puffer®, Americig®, Fumare™, Hookah Stix® and Smoke Star®. We also design and develop private label brands for some of our distribution customers. "Electronic cigarettes" or "e-cigarettes," are battery-powered products that enable users to inhale nicotine vapor without smoke, tar, ash or carbon monoxide. Vapor's electronic cigarettes and accessories are available online, through direct response to our television advertisements and through retail locations throughout the United States. For more information on Vapor Corp. and its e-cigarette brands, please visit us at www.vapor-corp.com

SOURCE Vapor Corp.

CROS NT Ltd Announces Acquisition of MDSL International Ltd.

LONDON, Jan. 7, 2014 /PRNewswire-iReach/ -- As part of the CROS NT Group global growth strategy, CROS NT Ltd today announced the acquisition of MDSL International - a specialist clinical Contract Research Organization (CRO) providing biometrics services such as Clinical Data Management and Statistical services. The financial details of the transaction remain confidential.

CROS NT Ltd, the UK branch of CROS NT, sees the acquisition as an important part of the overall group strategy. The deal adds additional resources to the existing group in the UK and will provide a new headquarters for the UK company in Maidenhead, close to London. MDSL International has built a reputation for providing strong consultancy and project work coupled with excellent customer service.

Andrew MacGarvey, CEO and President of CROS NT, said, "I am delighted to expand the UK operation through this acquisition. We are adding a highly experienced team to the business and further diversifying our customer base – both important objectives of the CROS NT Group. We will move our UK Headquarters to Maidenhead, giving us a great location in terms of on-going recruitment and access by our customers given its proximity to London. Coming shortly after our acquisition of Stat-tech Services in the USA, this deal demonstrates our commitment to place expertise close to our customers and to grow to meet the increasing demand for our services."

Edmund Otun, the founder of MDSL International, said, "I am pleased to have concluded the deal with CROS NT. Being part of a larger entity allows us to provide additional resources to our existing clients – something they have been asking for. CROS NT has a very strong management team, with great experience in the CRO business. I will remain with the company providing consultancy for emerging companies seeking advice on getting their products to market or securing licencing deals."

Jo Marshall, MDSL International Managing Director, who will become the UK Country Manager for CROS NT Ltd added, "I am excited by this opportunity and looking forward to working with the CROS NT team. In addition to giving us greater critical mass here in the UK, this deal will give our existing customers access to the CROS NT technology portfolio which includes several Electronic Data Capture (EDC) platforms, a Clinical Trial Management System (CTMS), and electronic Patient Reported Outcomes (ePRO) solutions."

About CROS NT

In its 22nd year, CROS NT is a global Contract Research Organization (CRO) specialized in clinical data services. With over 800 studies completed in a variety of therapeutic areas and indications, CROS NT has remained focused on biometrics including statistical consultancy, programming and analysis, clinical data management, medical writing, pharmacovigilance and life science technology solutions. We collect, integrate and analyze data from various sources and uses processes and technology to ensure excellent project governance, reporting and traceability.

About MDSL International Limited

MDSL is a private company and was founded by the Executive Chairman Dr. Edmund Otun in April 1996 to provide data management and statistical services to the pharmaceutical industry. We continue today to provide a fully project managed, flexible service from start to finish on a wide range of clinical trials for our European biotechnology and pharmaceutical customers. The principles upon which the company was founded are as valid today as they were in 1996. They are to provide superior service and quality with commitment and integrity whilst providing a work life balance for employees conducive to flexibility, motivation and versatility.

Media Contact: Mary Wieder, CROS NT, +39 045 820 26 66, mary.wieder@crosnt.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE CROS NT

reade more...

Dynasil Regains Compliance with NASDAQ Listing Requirements

WATERTOWN, Mass., Jan. 7, 2014 /PRNewswire/ -- Dynasil Corporation of America ("Dynasil" or the "Company") (NASDAQ: DYSL), a developer of sensing, detection and analysis technology for homeland security, medical and industrial applications, announced today that it has regained compliance with the $1.00 minimum bid price requirement for continued listing on the NASDAQ Capital Market.

As previously announced, on March 26, 2013, NASDAQ notified the Company that the closing bid price of Dynasil's common stock had fallen below $1.00 per share over the previous 30 consecutive business days and, as a result, the Company was not in compliance with the minimum bid requirement.

On January 7, 2014, NASDAQ notified the Company that the closing bid price of its common stock had been $1.00 per share or greater for 10 consecutive business days. Accordingly, Dynasil has regained compliance and the NASDAQ now considers the matter closed.

About Dynasil
Dynasil Corporation of America (NASDAQ: DYSL) develops and manufactures optical detection and analysis technology and components for the homeland security, medical and industrial markets. Combining world-class expertise in research and materials science with extensive experience in manufacturing and product development, Dynasil is commercializing products including dual-mode radiation detection solutions for Homeland Security and commercial applications and sensors for non-destructive testing. Dynasil has an impressive and growing portfolio of issued and pending U.S. patents. The Company is based in Watertown, Massachusetts, with additional operations in Mass., Minn., NY, NJ and the United Kingdom. More information about the Company is available at www.dynasil.com.

Contact:
Patty Kehe
Corporate Secretary
Dynasil Corporation of America
Phone: (617) 668-6855
pkehe@dynasil.com

SOURCE Dynasil Corporation of America

LG Jumps Into Fitness Tech At CES With Lifeband Touch And Heart Rate Earphones

LG Electronics logo. (PRNewsFoto/LG Electronics USA, Inc.)jwplayer.key="2kY/GKwZ2uQZmDlQ9VYArfZt2b4+KhHX3+DM4zisgtE=";LAS VEGAS, Jan. 6, 2014 /PRNewswire/ -- LG Electronics (LG) today took the wraps off LG Lifeband Touch and LG Heart Rate Earphones, two wearable products that mark the company's first foray into fitness tech. Unveiled at the 2014 International Consumer Electronics Show (CES) in Las Vegas, both products incorporate comfortable designs and compatibility with other devices so that monitoring one's health requires no additional effort beyond strapping on a watch and inserting a pair of headphone earbuds.

(Logo: http://photos.prnewswire.com/prnh/20110203/CG42292LOGO-d)

Lifeband Touch is a smart activity tracker that incorporates a bold yet comfortable design and is compatible with heart rate monitors (HRM) as well as smartphones. Meanwhile, the innovative Heart Rate Earphones' unique dual-function design offers a convenient way for users to measure their heart rate while exercising. Both devices are designed to help users take greater control over their health. Lifeband Touch and Heart Rate Earphones can wirelessly link up to each other, creating a seamless wearable ecosystem. Connected to smartphones (Android and iOS supported), the devices can transmit data to the intuitive, easy-to-use LG Fitness app, or to a number of other third party apps such as MyFitnessPal, Runkeeper or MapMyFitness.

Lifeband Touch was designed to be asymmetric and flexible, providing greater comfort and style than other wearable fitness wristbands. Featuring a touch OLED panel to display time, biometrics, incoming calls and music controls, the built-in 3-axis accelerometer and altimeter allows the device to accurately measure key performance indicators such as distance, speed, number of steps, calories consumed and projected pace. All this information is visible with a swipe of a finger on the OLED display. Engineered to be lightweight and simple to use, it incorporates a unique motion-sensing algorithm that automatically turns on the display when the wearer rotates his or her wrist. Lifeband Touch also offers wireless connectivity via Bluetooth to transmit data to a smartphone or receive data from third party devices such the Heart Rate Earphones.

LG's Heart Rate Earphones feature PerformTek® sensor technology which measures blood flow signals from the auricle, the external part of the ear to capture accurate biometric data such as heart rate and maximal oxygen consumption (VO2 max). As a continuous heart rate monitoring device, PerformTek® has proven accurate during rigorous physical activity. LG employs a flexible ear piece design to make its Heart Rate Earphones more comfortable to use than other similar monitoring devices. A clip-on medallion connected to the earphones provides Bluetooth connectivity, enabling the unit to send data to a smartphone or the Lifeband Touch for a truly seamless experience.

"We wanted to introduce wearable fitness products that met the expectations of today's tech savvy consumers and brought something new to the table, which in our case meant exceptional design, comfort and functionality," said Jim Clayton, executive vice president of LG's New Business Division in the Home Entertainment Company. "The uniqueness of our wearable devices is that they weren't just designed for exercise but also for day-to-day use in the office or around the home. With Lifeband Touch, you can get call and text notifications sent from your smartphone while the Heart Rate Earphones are perfectly happy playing back music all day even when you're not exercising. These are much more than just fitness devices."

Lifeband Touch and Heart Rate Earphones will be available starting in the United States in the first half of 2014, to be followed by rollouts in other markets. Visitors to LG's booth at CES 2014 (Las Vegas Convention Center, Central Hall #8204) from January 7 through January 10 will be able to see and experience LG's newest wearable devices for themselves.

About LG Electronics, Inc.
LG Electronics, Inc. (KSE: 066570.KS) is a global leader and technology innovator in consumer electronics, mobile communications and home appliances, employing 87,000 people working in 113 locations around the world. With 2012 global sales of USD 45.22 billion (KRW 50.96 trillion), LG comprises five business units — Home Entertainment, Mobile Communications, Home Appliance, Air Conditioning & Energy Solution and Vehicle Components — and is one of the world's leading producers of flat panel TVs, mobile devices, air conditioners, washing machines and refrigerators. LG Electronics is a 2013 ENERGY STAR® Partner of the Year. For more news and information on LG Electronics, please visit www.LGnewsroom.com.

About LG Electronics Home Entertainment Company
The LG Electronics Home Entertainment Company is a global top player in televisions, monitors, commercial displays, audio video systems, personal computers and security systems. The company constantly pushes technological boundaries to create feature-rich devices with stylish designs that meet global consumer needs. LG's consumer products include OLED TV, Ultra HD TV, CINEMA 3D Smart TV, IPS monitors, home theater systems, Blu-ray Disc™ players, car audio video systems, mouse scanners and external storage devices. LG's commercial products include digital signage, video conferencing systems and IP security cameras.

SOURCE LG Electronics USA, Inc.

reade more...

SensoMotoric Instruments Unveils SMI RED-n Consumer Eye Control Technology for Gaming and Computing

SensoMotoric Instruments Unveils SMI RED-n Consumer Eye Control Technology for Gaming and Computingjwplayer.key="2kY/GKwZ2uQZmDlQ9VYArfZt2b4+KhHX3+DM4zisgtE=";BOSTON, BERLIN and TELTOW, Germany, January 6, 2014 /PRNewswire/ --

The RED-n eye tracker by SensoMotoric Instruments' (SMI) brings robust, accurate and precise eye tracking technology with unprecedented small form factor at a mass market price to OEMs and consumer applications.

(Photo: http://photos.prnewswire.com/prnh/20140106/662834 )

The doors open at CES 2014 and SensoMotoric Instruments (SMI), a world leader in eye and gaze tracking for over 20 years, announces their RED-n eye tracking technology that will change how people control their tablets, laptops and desktop PCs and how they play and experience the next generation of video games. SMI's product development team has listened carefully to SMI's best in class OEM partners who use SMI eye tracking technology along with gaming, computer hardware, assistive devices and professional applications. As a result, the SMI RED-n opens up new ways for people to use eye control in their daily tasks - truly natural and productive.

The technology is already available for evaluation by OEM customers. SMI is working with a partner to announce a general available eye tracking peripheral for individual developers and dedicated end user applications in Q1/14.

The next-generation algorithms of the SMI RED-n deliver unprecedented robustness and highest accuracy for monitor sizes up to 28", and free head movements in a range more than four times larger compared to the current market available technology. With only 8mm thickness, the RED-n hardware components can be integrated into almost any device such as tablets, laptops and monitors or can been used as an externally attached eye tracking accessory.

Christian Villwock, Director of SMI´s OEM Solutions Business: "We've listened carefully to our partners, so that this new generation of our well established eye tracking technology outperforms in all relevant dimensions the existing eye tracking solutions while allowing a mass market's price for volume applications."

SMI OEM Website: http://www.smivision.com/oem-eye-tracking/index.html

Learn more about SensoMotoric Instruments (SMI) at http://www.smivision.com

Contact SMI: Stefanie Gehrke, Marcom Manager, stefanie.gehrke@smi.de, +49(0)172-3808-537

SMI on Facebook: http://www.facebook.com/smieyetracking

SMI on Twitter: http://www.twitter.com/smieyetracking

SMI on Flickr: http://www.flickr.com/smieyetracking

SMI on YouTube: http://www.youtube.com/smieyetracking

SMI on Google+: http://gplus.to/smieyetracking

Phone : +49(0)3328-3955-00
Fax : +49(0)3328-3955-99
WEB : http://www.smivision.com
E-Mail : info@smivision.de
SensoMotoric Instruments GmbH
Warthestrasse 21
Germany
14513 Teltow

SOURCE SensoMotoric Instruments GmbH

reade more...

ZIO ® service identifies arrhythmias significantly more than the traditional Holter Monitor, according to study published online in the American Journal of medicine

SAN FRANCISCO, 02 January 2014/PRNewswire /-iRhythm Technologies, a company of services of health information, today announced that a prospective study from the Scripps Translational Science Institute (STSI) has found that the use of the service of the company ZIO significantly increased detection of cardiac arrhythmias, compared to the use of the traditional Holter monitor. Findings, published and made publicly accessible online in the January issue of the American Journal of Medicine, underscore the role of the service ZIO, ZIO, patented algorithms patch and ZIO review, as the new standard for the ambulatory monitoring of patients with suspected arrhythmia.

"This is the first large prospective validation that this new technology passed the device invented by Norman Holter in 1949," said the lead author of the study, Dr. Eric Topol, a cardiologist who directs STSI and serves as the academic director of Scripps Health. "By tracking every beat of the heart up to two weeks, ZIO service proved to be significantly more sensitive than the Holter standard, it uses multiple threads and it is normally only used or tolerated during 24 hours.

"For" millions of people who presented each year with suspected arrhythmia, this could to be the new standard for the capture of the electric guilty heart rhythm disturbance, most commonly atrial fibrillation that carries a significant risk of race, he said.

The prospective study included 146 consecutive patients of Scripps Health who were referred for evaluation of cardiac arrhythmias and underwent an outpatient monitoring simultaneous ECG with ZIO patch, a patch on the chest, which continuously monitor the heartbeat records up to 14 days and a conventional 24-hour Holter, a portable machine with multiple cables that connect to the electrodes on the chest. Total wear of both devices, the service of ZIO time detected events of arrhythmia 57% more in comparison with the Holter monitor (96 against 61), mainly due to the prolonged monitoring. The doctors also reported that they reached a definitive diagnosis in 90% of cases using the ZIO service, compared with 64% with the Holter monitor. In addition, 81% of the patients reported that they preferred the ZIO patch versus the Holter monitor.

"The traditional options of monitoring heart are limited in their ability to capture the arrhythmias, which are rare and often do not have symptoms, and because they are difficult for patients to comply", said Kevin King, President and Chief Executive Officer of iRhythm. "These studies findings underscore that the ZIO service is setting a new standard for the diagnosis of arrhythmia, with a focus continuous monitoring proven, long-term which allows doctors to rule in and rule out arrhythmias before in the way of diagnosis and change the treatment of the patients."

Each year, millions of patients presenting with low common and non-specific symptoms such as palpitations, dizziness, and shortness of breath, which may or may not be caused by cardiac arrhythmias. Reports estimate that the three most common types of arrhythmia, atrial fibrillation (AF), bradycardia and ventricular tachycardia - affect approximately 8 million people in the United States each year. If it is not correctly, arrhythmias can lead to serious complications such as stroke. Effective management of cardiac arrhythmia is specific to the identified type of arrhythmia. Arrhythmias, however, are often difficult to diagnose using techniques of monitoring current, that they are limited in what you can record or it can be difficult for patients to use or tolerate.

About ZIO service
Service ZIO, ZIO, patented algorithms patch and ZIO report, is recognized more and more as the new standard for patients with suspected arrhythmia ambulatory cardiac monitoring. ZIO patch is a non-invasive, resistant to water, which is easy to use and discreet to wear, high compliance of the patient and a higher diagnostic yield. Proprietary algorithms analyze the data hit captured heart and provides a concise report to the patient's physician. Since its commercial launch in 2011, has been ZIO service with more than 200,000 patients in nearly 800 institutions throughout the country. ZIO is covered by most Medicare patients and main payers private throughout the country, representing more than 150 million of lives covered.

About iRhythm Technologies, Inc.
iRhythm is a company of services of health information that aims to be the world leader in information of cardiac arrhythmia management, a large and growing clinical need. Your solution of ship logo, ZIO service, offers an approach proven for continuous monitoring in the long term that allows early diagnosis in the clinical way to improve patient outcomes and reduce healthcare costs. For more information, visit www.irhythmtech.com.

Press contact:

Tracy Morris
650-380-4413
tracymorrispr@gmail.com

SOURCE iRhythm Technologies

RELATED LINKS
http://www.irhythmtech.com

reade more...

Synaptics interface industry-leading solutions in 2014 human Consumer Electronics Show

LAS VEGAS, 02 January 2014/PRNewswire /-Synaptics Inc. (NASDAQ: ball gown strapless floor), a leading developer of human interface solutions, announced today will feature several innovations of milestone in 2014 Consumer Electronics Show (CES) in Las Vegas from January 7 to January 10. On the heels of a great year for the advancement of human interface, the company will highlight several solutions industry for commercially will debut in 2013, while also providing visitors with a vision towards the future of human interface technology.

Innovation today - human interface main milestones of the year 2013

® ClearPad 3350:First full high definition industry in-cell touch screen is powered by the solution of driver ClearPad 3350 single-chip touch that is integrated directly into the touch screen, delivering Nexus 5 users best-in-class touch sensitivity and experience 10-finger multi-touch. ClearPad ® single layer of cells (maintenance): maintain ClearPad solution is the first to merge the touch screen sensor and glass liquid (LCD) together in an elegant pile, allowing finer, lighter smartphone designs that became commercially available for the first time in 2013 via the G bike and Yulong Coolpad, smartphone 8908 entry-level for the China market. 3D-Touch ™: feeding the Samsung Galaxy S4 in 2013 as AirView ™, this gesture technology extends the possibilities of user interface with proximity, libration and air functionality at once with the fingers. TypeGuard ™: software TypeGuard technology virtually eliminates the movements of the cursor false, accidental taps and false edge scrolls distinguishing between a finger and a Palm, giving a more accurate response to users during everyday use. ForcePad ®: award-winning, pressure-sensitive TouchPad Synaptics for laptops, which includes TypeGuard, brings a new dimension of control users and became commercially available for the first time in 2013 with a leader of the OEM. ClickPad purpose ™ 2.0: appointed as International CES innovation 2014 design and Engineering Award Honoree, ClickPad aim 2.0 with TypeGuard is the most advanced portable sensor capacitive TouchPad technology available with leading OEM, offering best in class and industry more responsive and coherent, durability click performance.Interface human innovations tomorrow - a look at the future

Concept prototypes:Tradition of Synaptics continuous reflection human interface solutions and game-changing, the company once more will feature innovative prototypes, including a TouchPad proximity enabled, a haptic-enabled touchscreen, touch touch screen, a new set of user experiences in the proximity and more-capable phones. Fingerprint authentication: following its acquisition of 2013 biometrics, Synaptics will highlight new touch capabilities identity with authentication solutions to address the explosive growth of this technology in consumer devices. New biometrics team Synaptics will be demonstrating products enabling highly suitable security, without friction for everything from mobile payment, access to mobile security transactions enterprise and cloud-based services. ThinTouch ®:Keyboard solutions delivers unprecedented performance, driven in part by shrink keys and detection of presence of thinness, Synaptics capacitive sensors capabilities-driven finger it will highlight in a series of demo platforms. Synaptics will exhibit broadest family of solutions industry in an area of private meeting (LVCC, South Hall 2, #MP25340) from January 7 to January 10 appointment. Customers and suppliers are encouraged to contact your partner of Synaptics to arrange a meeting at CES. The media are encouraged to contact synaptics@text100.com to arrange on-site interviews.

For last minute Synaptics news, follow @SynaCorp on Twitter. For more information about products and solutions of Synaptics, visit www.synaptics.com.

About Synaptics
As a leading developer of human interface solutions that improve the user experience, Synaptics offers the broadest portfolio of industry solutions. ® ClearPad family supports touch screen solutions for devices ranging from mobile phones of entry-level flagship premium smartphones, tablets and laptops. The TouchPad ™ family, including ClickPad purpose ™ and ForcePad ®, is integrated in most notebooks today. LiveFlex ® fingerprint sensor technology enables authentication, mobile payments, and touch navigation for smartphones, tablets and laptops. Broad portfolio of Synaptics also includes ThinTouch ® solutions to support keyboard slim and lightweight, as well as the key technologies for the next generation touch screen enabled applications and video. (NASDAQ: ball gown strapless floor) www.synaptics.com.

Synaptics TouchPad, ClearPad, ClickPad purpose, ForcePad, ThinTouch, LiveFlex, and the Synaptics logo are trademarks of Synaptics in the United States and/or other countries. All other trademarks are the property of their respective owners.

For more information, please contact:
Nick Rottler
Synaptics
408-904.1820
nrottler@Synaptics.com

Starlayne Meza
Text 100 global communications
415-593-8431
Synaptics@text100.com

SOURCE Synaptics Inc.

Pages

.